A new study paves the way for the development of next generation therapeutics for the prevention and treatment of Clostridioides difficile infection (CDI), the most frequent cause of healthcare-acquired gastrointestinal infections and death in developed countries.
New therapeutic target for C. difficile infection
- ScienceDaily
- 18. 6 2021 (19:41)